Treatment Approaches to Lacunar Stroke

Total Page:16

File Type:pdf, Size:1020Kb

Treatment Approaches to Lacunar Stroke ARTICLE IN PRESS Review Article Treatment Approaches to Lacunar Stroke , , Alvin S. Das, MD,* † Robert W. Regenhardt, MD, PhD,* † Steven K. Feske, MD,† and Mahmut Edip Gurol, MD* Lacunar strokes are appropriately named for their ability to cavitate and form ponds or “little lakes” (Latin: lacune -ae meaning pond or pit is a diminutive form of lacus meaning lake). They account for a substantial proportion of both symptomatic and asymptomatic ischemic strokes. In recent years, there have been several advan- ces in the management of large vessel occlusions. New therapies such as non-vita- min K antagonist oral anticoagulants and left atrial appendage closure have recently been developed to improve stroke prevention in atrial fibrillation; how- ever, the treatment of small vessel disease-related strokes lags frustratingly behind. Since Fisher characterized the lacunar syndromes and associated infarcts in the late 1960s, there have been no therapies specifically targeting lacunar stroke. Unfortu- nately, many therapeutic agents used for the treatment of ischemic stroke in general offer only a modest benefit in reducing recurrent stroke while adding to the risk of intracerebral hemorrhage and systemic bleeding. Escalation of antithrombotic treat- ments beyond standard single antiplatelet agents has not been effective in long- term lacunar stroke prevention efforts, unequivocally increasing intracerebral hem- orrhage risk without providing a significant benefit. In this review, we critically review the available treatments for lacunar stroke based on evidence from clinical trials. For several of the major drugs, we summarize the adverse effects in the con- text of this unique patient population. We also discuss the role of neuroprotective therapies and neural repair strategies as they may relate to recovery from lacunar stroke. Key Words: Cerebrovascular diseases—stroke—lacunar stroke—cerebral small vessel disease © 2019 Elsevier Inc. All rights reserved. Introduction and Basic Definitions Lacunar strokes (LS), which account for approximately From the *Department of Neurology, Massachusetts General Hos- 20%-30% of all ischemic strokes,1,2 are largely due to the pital, Harvard Medical School, Boston, Massachusetts; and †Depart- pathologic consequences of underlying cerebral small ves- ment of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts. sel disease (cSVD). While LS is one sequela of cSVD, cSVD Received January 21, 2019; revision received April 15, 2019; is a major contributor to several neurological comorbid- accepted May 2, 2019. ities, including vascular cognitive impairment, gait disor- Funding: Funding for this study was provided by grants from the ders, and intracerebral hemorrhage (ICH).3-8 In addition National Institutes of Health (M. Edip Gurol, NS083711; Robert W. to lacunar cavitations, cSVD has many neuroimaging Regenhardt, NS065743). Address correspondence to M. Edip Gurol, MD, Department of manifestations including white matter hyperintensities Neurology, Hemorrhagic Stroke Research Program, Massachusetts (WMH), cerebral microbleeds, dilated perivascular General Hospital, 175 Cambridge Street, Suite 300, Boston, MA spaces, superficial cortical siderosis, and brain atrophy. 02114. E-mail address: [email protected]. By the historical classification schema outlined in the Trial 1052-3057/$ - see front matter of Org 10172 in Acute Stroke Treatment (TOAST), small © 2019 Elsevier Inc. All rights reserved. fi https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.05.004 artery occlusions (LS) were de ned as meeting the Journal of Stroke and Cerebrovascular Diseases, Vol. &&, No. && (&&), 2019: &&À&& 1 ARTICLE IN PRESS 2 A.S. DAS ET AL. ACRONYM DEFINITION FMS Fugl-Meyer motor scale FOCUS Functional Outcomes after Acute ACTIVE Atrial Fibrillation Clopidogrel Trial Stroke with Irbesartan for Prevention GABA g-aminobutyric acid of Vascular Events GI gastrointestinal ADC apparent diffusion coefficient GOS Glasgow Outcome Scale aICH asymptomatic intracerebral HbA1c hemoglobinA1c hemorrhage HR hazard ratio fi AICLA Accidents Ischemiques Cerebraux ICD International Classi cation of Lies a l’Atherosclerose Diseases ALIAS Albumin Treatment for Ischemic ICH intracerebral hemorrhage Stroke INR international normalized ratio AMPA a-amino-3-hydroxy-5-methyl-4-iso- IRIS Insulin Resistance Intervention after xazolepropionic acid Stroke ASA aspirin IS ischemic stroke ATC Antithrombotic Trialists IST-3 Third International Stroke Trial Collaboration IU International Unit ATLANTIS Alteplase ThromboLysis for Acute IV intravenous Noninterventional Therapy in JCS Joint Committee for Stroke Ischemic Stroke LAA large artery atherosclerosis BI Barthel index LAAC left atrial appendage closure C controlled LACI lacunar infarction CAA cerebral amyloid angiopathy LACI-2 LACunar Intervention-2 CAPRIE Clopidogrel versus AsPirin in LS lacunar stroke patients at Risk of Ischaemic Events MATCH Management of AtheroThrombosis CASISP Cilostazol versus Aspirin for Sec- with Clopidogrel in High-risk ondary Ischemic Stroke Prevention patients CAST Chinese Acute Stroke Trial MC multicenter CD clopidogrel mg milligram CE cardioembolic MI myocardial infarction CHANCE Clopidogrel in High-Risk Patients mm millimeter with Acute Nondisabling mmHg millimeter of mercury Cerebrovascular Events MRI magnetic resonance imaging fi CI confidence interval mRS modi ed Rankin scale CS cilostazol NE neurological examination CSPS Cilostazol Stroke Prevention Study NIHSS National Institutes of Health Stroke CSPS.com Cilostazol Stroke Prevention Study for Scale Antiplatelet Combination (CSPS.com) NINDS National Institute of Neurological cSVD cerebral small vessel disease Disorders and Stroke CT computed tomography NMDA N-methyl-D-aspartate receptor À DAPT dual antiplatelet therapy NOAC non vitamin K antagonist oral DB double-blind anticoagulants DP dipyridamole NOGO neurite outgrowth inhibitor DWI diffusion-weighted imaging NR not reported ECASS European Cooperative Acute Stroke O other Study OCSP Oxfordshire Community Stroke EPITHET EchoPlanar Imaging Thrombolytic Project Evaluation Trial OHS Oxford Handicap Scale ESPRIT European/Australasian Stroke Pre- PACI partial anterior circulation infarct vention in Reversible Ischaemia Trial PE physical exam ESPS-2 European Stroke Prevention Study-2 PI pulsatility index FLAIR fluid-attenuated inversion recovery PLATO Platelet Inhibition and Patient FLAME Fluoxetine for Motor Recovery after Outcomes Acute Ischemic Stroke POCI posterior circulation infarct ARTICLE IN PRESS TREATMENT APPROACHES TO LACUNAR STROKE 3 separates the lesion attributed to small vessel disease into POINT Platelet-Oriented Inhibition in New several subtypes: recent small subcortical infarct and TIA and minor ischemic stroke lacune of presumed vascular origin.10 This terminology PRoFESS Prevention Regimen for Effectively reflects a more complete understanding of the dynamic Avoiding Second Strokes nature of cSVD such that not all subcortical infarcts form PS prospective lacunar cavities but instead may form acute and chronic R randomized WMH.11,12 Furthermore, while subcortical infarctions are RRR relative risk reduction often accompanied by the clinical syndromes originally RS retrospective described by Fisher and others,13 subcortical infarctions RT randomized can be identified incidentally by diffusion-weighted imag- SATURN StATins Use in IntRacerebral Hem- ing (DWI) sequences on MRI scans.14-17 orrhage PatieNts By consensus definitions set forth by the STRIVE con- SC single-center sortium, recent small subcortical infarcts can be up to sICH asymptomatic intracerebral 20 mm in axial diameter on MRI and are attributed to hemorrhage infarcts in the territory of the arteriole perforator.10 SOCRATES Acute Stroke or Transient Ischemic Lesions larger than 20 mm in the basal ganglia are Attack Treated with Aspirin or Tica- excluded from this definition, because they may be caused grelor and Patient Outcomes by an infarct affecting several arteriolar penetrators. SPARCL Stroke Prevention by Aggressive Lacunes of presumed vascular origin are the end products Reduction in Cholesterol Levels of small subcortical infarcts (Fig 1), although they can SPIRIT Stroke Prevention in Reversible sometimes be difficult to distinguish from old hemor- Ischemia Trial rhages or large perivascular spaces. These lacunes are fre- SPS3 Secondary Prevention of Small Sub- quently observed on neuroimaging scans of cortical Strokes 3 neurologically “healthy” individuals, although they con- SSRI selective serotonin reuptake fer an increased risk of symptomatic stroke and vascular inhibitors cognitive impairment.5,18-23 Lacunes of presumed vascu- STRIVE STandards for ReportIng Vascular lar origin are subcortical, round, fluid-filled spaces changes on nEuroimaging between 3 mm and 15 mm (smaller than subcortical SWI susceptibility-weighted imaging infarcts due to chronic involution of tissue). Compared to TACI total anterior cerebral infarct dilated perivascular spaces, lacunes have a surrounding TIA transient ischemic attack T2 hyperintense rim and are usually larger than the 3 mm TOAST Trial of ORG 10172 in Acute Stroke size cutoff for these lesions.10,24,25 Lacunes are classically Treatment found in deep locations, although lobar lacunes have been TP ticlopidine recently characterized,26 and are likely associated with tPA tissue plasminogen activator cerebral amyloid angiopathy (CAA) (Fig 2). For purposes UD undetermined of this review, small subcortical infarcts and their accom-
Recommended publications
  • Lacunar Stroke
    Lacunar Stroke Prior to making any medical decisions, please view our disclaimer. Clinical Lacunar Syndrome Lacunar strokes tend to occur in patients with diabetes, hyperlipidemia, smoking or chronic hypertension and may be clinically silent or present as pure motor hemiparesis, pure sensory loss, or a variety of well-defined syndromes (e.g., dysarthria-clumsy hand, ataxic- hemiparesis). Descending compact white matter tracts or brainstem gray matter nuclei are injured, often producing widespread and striking initial deficits. However, the prognosis for recovery with lacunar stroke is better than with large artery territory stroke, and for this reason many centers favor using antiplatelet therapy (aspirin, clopidogrel) or conservative management rather than thrombolytic therapy for uncomplicated lacunar stroke. The risk of hemorrhagic transformation or edema in these patients is extremely low. Because initial clinical presentation may be deceiving particularly in the posterior circulation, all patients presenting with acute ischemic symptoms should undergo some form of neurovascular imaging to establish large vessel patency (CTA, MRA, ultrasound or angiography). Management Algorithm Phase 1 Additional Diagnostic Testing • Consider fasting lipids, lipoprotein (a), B12, folate, homocysteine • If suspicious of large vessel atheroma producing penetrator infarction, refer to algorithm for Large Vessel disease Prevention of Acute Recurrent Stroke • Consider antiplatelet therapy (e.g., aspirin, clopidogrel, ticlopidine, persantine, integrilin,
    [Show full text]
  • Definition of Stroke/Brain Attack
    Definition of Stroke/Brain Attack Stroke II: • A syndrome caused by disruption in the flow of Diagnosis, Evaluation, and Prevention blood to part of the brain due to either: – occlusion of a blood vessel • ischemic stroke Lenore N. Joseph, MD – rupture of a blood vessel Neurology Service Chief, McGuire VAMC • hemorrhagic stroke Assistant Professor of Neurology • The interruption in blood flow deprives the brain VCU Health System of nutrients and oxygen resulting in injury to cells Medical College of Virginia in the affected vascular territory of the brain 1 2 Stroke: The Problem Stroke: The Problem • Third leading cause of death in US • Among 6 month or longer survivors: – after heart disease and cancer – 48% have a hemiparesis • 740,000 new strokes each year – 22% cannot walk • 4.5 million stroke survivors – 24-53% report complete or partial • Leading cause of disability in adults in US dependence for activities • $45.5 billion per year in the USA – 12-18% are aphasic • 1 of 6 Americans will be affected – 32% are clinically depressed – only 10% fully recover 3 4 Symptoms of Brain Attack: Symptoms of Brain Attack: Teach your patients! Teach your patients! • Sudden weakness, paralysis, or numbness of: • Sudden unexplained dizziness –face – especially when associated with other – arm and the leg on one or both sides of the neurologic symptoms body – unsteadiness • Sudden loss of speech, or difficulty speaking or – sudden falls understanding speech • Sudden severe headache and/or loss of • Sudden dimness or loss of vision consciousness –
    [Show full text]
  • To Study the Incidence of Lacunar Infarcts in Patients with Acute Ischemic Stroke and Its Correlation with Carotid Artery Stenosis 1Harmanpreet Singh, 2Gurinder Mohan
    CTDT 10.5005/jp-journals-10055-0045 ORIGINAL RESEARCH ARTICLE To Study the Incidence of Lacunar Infarcts in Patients with Acute Ischemic Stroke and its Correlation with Carotid Artery Stenosis 1Harmanpreet Singh, 2Gurinder Mohan ABSTRACT Stroke and its Correlation with Carotid Artery Stenosis. Curr Trends Diagn Treat 2018;2(2):88-91. Introduction: Stroke remains the second leading cause of death worldwide, after ischemic heart disease. Lacunar Source of support: Nil infarcts are small deep infarcts ranging from 2 to 20 mm in Conflict of interest: None size resulting from occlusion of a penetrating artery which accounts for approximately 25% of all ischemic strokes. The present study was undertaken to study the incidence of lacunar infarcts in patients with acute ischemic stroke and its INTRODUCTION correlation with carotid stenosis. Stroke remains the second leading cause of death world- 1 Materials and methods: This study was performed at the wide, after ischemic heart disease. Early diagnosis Department of Medicine at a tertiary-care hospital in Amritsar, and treatment is necessary to prevent mortality and Punjab, in 50 patients presenting with acute ischemic stroke morbidity. 2 Stroke or cerebrovascular accident is a clini- with or without lacunar syndrome. All patients were diagnosed cal syndrome, and has been defined by the World Health using diffusion-weighted imaging (DWI) on magnetic resonance imaging (MRI) of the brain. Carotid artery stenosis was measured Organization (WHO) as “rapidly developing clinical with duplex ultrasound. signs of focal (at times global) disturbance of cerebral function, lasting more than 24 hours or leading to death Results: Patients with acute ischemic stroke had a mean age of 61.36 ± 11.36 years.
    [Show full text]
  • Blood Pressure Management in Stroke Patients
    eISSN 2508-1349 J Neurocrit Care 2020;13(2):69-79 https://doi.org/10.18700/jnc.200028 Blood pressure management in stroke patients REVIEW ARTICLE Seung Min Kim, MD, PhD1; Ho Geol Woo, MD, PhD2; Yeon Jeong Kim, MD, PhD3; Bum Joon Kim, MD, PhD3 Received: October 15, 2020 Revised: November 14, 2020 1Department of Neurology, VHS Medical Center, Seoul, Republic of Korea Accepted: November 26, 2020 2Department of Neurology, Kyung Hee University School of Medicine, Seoul, Republic of Korea 3Department of Neurology, Asan Medical Center, Seoul, Republic of Korea Corresponding Author: Bum Joon Kim, MD, PhD Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43- gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3981 Fax: +82-2-474-4691 E-mail: [email protected] Hypertension is a major, yet manageable, risk factor for stroke, and the benefits of well-controlled blood pressure are well established. However, the strategy for managing blood pressure can differ based on the pathomechanism (subtype), stage, and treatment of stroke patients. In the present review, we focused on the management of blood pressure during the acute stage of intracerebral hemorrhage, subarachnoid hemorrhage, and cerebral infarction. In patients with cerebral infarction, the target blood pressure was discussed both before and after thrombolysis or other endovascular treatment, which may be an important issue. When and how to start antihyper- tensive medications during the acute ischemic stroke period were also discussed. In regards to the secondary prevention of ischemic stroke, the target blood pressure may differ based on the mechanism of ischemic stroke.
    [Show full text]
  • Similarities to Large Artery Vs Small Artery Disease
    ORIGINAL CONTRIBUTION The Course of Patients With Lacunar Infarcts and a Parent Arterial Lesion Similarities to Large Artery vs Small Artery Disease Oh Young Bang, MD, PhD; Sung Yeol Joo, MD; Phil Hyu Lee, MD; Uk Shik Joo, MD; Jae Hyuk Lee, MD; In Soo Joo, MD; Kyoon Huh, MD Background: The significance of occlusive lesions of Main Outcome Measures: Recurrent strokes and the the parent artery in patients with lacunar syndrome (LS) prognosis were registered for 1 year, and the outcome and small deep infarcts (SDIs) on diffusion-weighted im- of the PAD group was compared with that of the SAD aging remains unclear. and LAD groups. Objective: To compare the recurrence of stroke in pa- Results: During follow-up, there were 9 deaths (6 vas- tients with LS and SDIs between those with vs without a cular) and 18 recurrent strokes. The recurrence rate in parent arterial lesion. the PAD group (16%) was significantly higher than that in the SAD group (1%) (P=.01) but similar to that in the Design: Analysis of data from a prospective acute stroke LAD group (17%) (P=.87). The presence of the parent registry. arterial lesion was the only independent predictor of stroke recurrence in patients with LS and SDIs (odds ratio, 13.8; Setting: University hospital. 95% confidence interval, 1.5-123.9; P=.02). Patients: Using clinical syndrome, diffusion-weighted Conclusions: Although LS on examination, SDIs on dif- imaging, and vascular studies, we divided 173 patients fusion-weighted imaging, and a stable hospital course sug- into 3 groups: (1) parent arterial disease occluding deep gest lacunar stroke of benign course, our results indicate perforators (PAD), LS with SDIs, and a parent arterial le- that the PAD group represents an intracranial type of LAD.
    [Show full text]
  • Cryptogenic Stroke: Understanding the Definition and Excluding Treatable Causes
    Cryptogenic Stroke: Understanding the Definition and Excluding Treatable Causes December 5, 2016 Speaker Lee H. Schwamm, MD Executive Vice Chairman and Director of Stroke/TeleStroke Services, Department of Neurology and Director of TeleHealth, Massachusetts General Hospital Professor of Neurology, Harvard Medical School ©2015, American Heart Association 2 Disclosure s • Clinical trials consultant to Medtronic (Steering Committee VICTORY AF, REACT AF; Co-PI Stroke AF) • DSMB member for Novo-Nordisk DeVOTE trial, Penumbra Separator 3D trial • Chair, Stroke Clinical Workgroup AHA GWTG-Stroke ©2015, American Heart Association 3 Overview • What or when is a stroke cryptogenic ? • Discuss the nature of the stroke workup • Review the current data on occult causes of stroke • Review the role of occult AF in cryptogenic stroke ©2015, American Heart Association 4 Sec of Defense Donald Rumsfeld Briefing the Press on Cryptogenic Stroke • “Reports that say that something hasn't happened are always interesting to me, because as we know, there are known knowns; there are things we know we know. (e.g., lacunar stroke) • We also know there are known unknowns; that is to say we know there are some things we do not know. (e.g., cryptogenic stroke) • But there are also unknown unknowns – the ones we don't know we don't know. And if one looks throughout the history of our country and other free countries, it is the latter category that tend to be the difficult ones” (e.g., how often is a lacunar stroke cardioembolic?) Defense.gov News Transcript: DoD News
    [Show full text]
  • Lacunar Stroke: Mechanisms and Therapeutic Implications
    Cerebrovascular disease J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2021-326308 on 26 May 2021. Downloaded from Review Lacunar stroke: mechanisms and therapeutic implications Shadi Yaghi ,1 Eytan Raz ,2 Dixon Yang,2,3 Shawna Cutting,1 Brian Mac Grory,4 Mitchell SV Elkind,5 Adam de Havenon 6 1Department of Neurology, ABSTRACT overall prevalence of these risk factors is similar Brown University Warren Alpert Lacunar stroke is a marker of cerebral small vessel between lacunar stroke and other stroke subtypes,8 Medical School, Providence, some studies suggest that smoking, hypertension Rhode Island, USA disease and accounts for up to 25% of ischaemic 2Department of Radiology, NYU stroke. In this narrative review, we provide an overview and diabetes are particularly important risk factors Langone Health, New York, New of potential lacunar stroke mechanisms and discuss for lacunar stroke3 7 and that these risk factors may 9 York, USA be more prevalent in patients with lacunar stroke. 3 therapeutic implications based on the underlying Department of Neurology, NYU mechanism. For this paper, we reviewed the literature Among these risk factors, hypertension is most Langone health, New York, New York, USA from important studies (randomised trials, exploratory common in patients with lacunar stroke (68%), 3 7 9 4Department of Neurology, comparative studies and case series) on lacunar stroke followed by diabetes (30%). These studies were Duke Medicine, Durham, North patients with a focus on more recent studies highlighting performed when the control of risk factors, partic- Carolina, USA mechanisms and stroke prevention strategies in ularly hypertension, was less aggressive and more 5Department of Neurology, patients with lacunar stroke.
    [Show full text]
  • Time Course of Blood Pressure Control Prior to Lacunar TIA and Stroke Population-Based Study
    ARTICLE OPEN ACCESS Time course of blood pressure control prior to lacunar TIA and stroke Population-based study Linxin Li, DPhil, Sarah J.V. Welch, RGN, Sergei A. Gutnikov, DPhil, Ziyah Mehta, DPhil, Correspondence and Peter M. Rothwell, FMedSci, on behalf of the Oxford Vascular Study Dr. Rothwell Peter.rothwell@ Neurology 2018;90:e1732-e1741. doi:10.1212/WNL.0000000000005526 ® ndcn.ox.ac.uk Abstract CME Course Objective NPub.org/cmelist To determine the age-specific temporal trends in blood pressure (BP) before acute lacunar vs nonlacunar TIA and stroke. RELATED ARTICLE Editorial Methods Effective stroke prevention In a population-based study of TIA/ischemic stroke (Oxford Vascular Study), we studied 15- requires timely detection year premorbid BP readings from primary care records in patients with lacunar vs nonlacunar fi ≥ and smooth control of events (Trial of Org 10172 in Acute Stroke Treatment [TOAST]) strati ed by age (<65, 65 hypertension years). Page 907 Results Of 2,085 patients (1,250 with stroke, 835 with TIA), 309 had lacunar events. In 493 patients <65 years of age, the prevalence of diagnosed hypertension did not differ between lacunar and nonlacunar events (46 [48.4%] vs 164 [41.2%], p = 0.20), but mean/SD premorbid BP (44,496 BP readings) was higher in patients with lacunar events (15-year records: systolic BP [SBP] 138.5/17.7 vs 133.3/15.0 mm Hg, p = 0.004; diastolic BP [DBP] 84.1/9.6 vs 80.9/8.4 mm Hg, p = 0.001), mainly because of higher mean BP during the 5 years before the event (SBP 142.6/ 18.8 vs 134.6/16.6 mm Hg, p = 0.0001; DBP 85.2/9.7 vs 80.6/9.0 mm Hg, p < 0.0001), with a rising trend (ptrend = 0.006) toward higher BP leading up to the event (<30-day pre-event SBP: 152.7/16.1 vs 135.3/23.1 mm Hg, p = 0.009; DBP 87.9/9.4 vs 80.8/12.8 mm Hg, p = 0.05; mean BP ≤1 year before the event 145.8/22.0 vs 134.7/16.1 mm Hg, p = 0.001; 86.1/10.7 vs 80.4/9.8 mm Hg, p = 0.0001).
    [Show full text]
  • Pathogenetic and Prognostic Features of Lacunar Transient Ischaemic Attack Syndromes
    Journal ofNeurology, Neurosurgery, and Psychiaty 1993;56:1265-1270 1265 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.56.12.1265 on 1 December 1993. Downloaded from PAPERS Pathogenetic and prognostic features of lacunar transient ischaemic attack syndromes Gianluca Landi, Cristina Motto, Ermelinda Cella, Massimo Musicco, Susanna Lipari, Edoardo Boccardi, Mario Guidotti Abstract studies reporting a significantly lower preva- Lacunar ischaemic stroke syndromes are lence of emboligenic heart disease and of a well defined subgroup of ischaemic carotid artery stenosis among lacunar than strokes. To determine whether a similar among other ischaemic strokes.3-5 Diagnosis subgroup can be identified among of lacunar ischaemic stroke syndrome has patients with transient ischaemic attacks prognostic implications, too, as these patients (TIAs) we studied prospectively 102 con- have a more favourable long term outcome secutive patients within 24 hours of their than those with other subtypes of cerebral first TIA. Based on their history they infarction.67 Transposition of the lacunar were classified as lacunar TIA syn- hypothesis to TIAs is not straightforward, as dromes (LTIAS; n = 45) if isolated motor their short duration usually precludes objec- or sensory symptoms or their combina- tive verification of symptoms; thus, diagnosis tion had involved at least two of three of a lacunar TIA syndrome would have to body parts (face, arm, leg), whereas all rest on the patient's history and on the clini- other subjects were grouped as non-lacu- cian's possibility to fit it retrospectively into nar TIA syndromes (NLTIAS; n = 57). one of the lacunar syndromes. Despite this All patients were investigated according limitation, two papers have endeavoured to to a standardised protocol and followed distinguish a subgroup with small vessel dis- up for an average of 51 1 months.
    [Show full text]
  • Stroke School for Internists – Part 1
    Stroke School for Internists – Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures • I receive a stipend for my role as Medical Director of the Stroke Network of SEO • I have no commercial disclosures or conflicts of interest Three Main Objectives • 1. Obtain a history and examination in five minutes in the ED • 2. Identify the stroke syndrome • 3. Read a plain noncontrast CT scan of the head and recognize thrombus, infarction, hemorrhage 1. Stroke History and Exam • The history (~ 3minutes) is focused on enabling a thrombolysis decision • The exam (~ 2 minutes) has two main aims: – Confirm the clinical suspicion of stroke – Clarify the stroke syndrome and localization • Within 5 minutes there is usually enough information to diagnose stroke • This sets up imaging as the decision point for thrombolysis “Last known well” • Last seen normal, or last known well is the time of onset – Time of onset is not necessarily when the patient was found – Time of onset is not necessarily when there was an abrupt change if the patient changed from having a mild deficit to a severe deficit – “When was the last time today that Mr. Jones was seen to be walking and talking normally?” What are the symptoms? • Weakness in face, arm or leg • Speech: Is it aphasia, or something else? • Sensory and Vision: Do they notice bilateral stimulation? • Ataxia: “Felt dizzy”, “Had to hold on to wall” Chronology • How quickly did symptoms reach maximal severity? – Symptom onset is often described as sudden – But symptoms often worsen after “sudden onset”
    [Show full text]
  • Updates on Prevention of Hemorrhagic and Lacunar Strokes
    Updates on Prevention of Hemorrhagic and Lacunar Strokes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Tsai, Hsin-Hsi, Jong S. Kim, Eric Jouvent, and M. Edip Gurol. 2018. “Updates on Prevention of Hemorrhagic and Lacunar Strokes.” Journal of Stroke 20 (2): 167-179. doi:10.5853/jos.2018.00787. http:// dx.doi.org/10.5853/jos.2018.00787. Published Version doi:10.5853/jos.2018.00787 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:37298331 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Journal of Stroke 2018;20(2):167-179 https://doi.org/10.5853/jos.2018.00787 Special Review Updates on Prevention of Hemorrhagic and Lacunar Strokes Hsin-Hsi Tsai,a,b Jong S. Kim,c Eric Jouvent,d M. Edip Gurole aDepartment of Neurology, National Taiwan University Hospital, Taipei, Taiwan bDepartment of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan cDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea dDepartment of Neurology, University Paris Diderot, Paris, France eDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA Intracerebral hemorrhage (ICH) and lacunar infarction (LI) are the major acute clinical Correspondence: M. Edip Gurol Department of Neurology, manifestations of cerebral small vessel diseases (cSVDs). Hypertensive small vessel disease, cerebral Massachusetts General Hospital, amyloid angiopathy, and hereditary causes, such as Cerebral Autosomal Dominant Arteriopathy Hemorrhagic Stroke Research Program, 175 Cambridge Street, Suite with Subcortical Infarcts and Leukoencephalopathy (CADASIL), constitute the three common cSVD 300, Boston, MA 02114, USA categories.
    [Show full text]
  • Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: a Genetic Cause of Cerebral Small Vessel Disease
    REVIEW Print ISSN 1738-6586 / On-line ISSN 2005-5013 J Clin Neurol 2010;6:1-9 10.3988/jcn.2010.6.1.1 Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease Jay Chol Choi, MD, PhD Department of Neurology and Institute of Medical Science, Jeju National University School of Medicine, Jeju, Korea Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a single-gene disorder of the cerebral small blood vessels caused by mutations in the Notch3 gene. The exact prevalence of this disorder was unknown currently, and the number of reported CADASIL families is steadily increasing as the clinical picture and diagnostic ex- aminations are becoming more widely known. The main clinical manifestations are recurrent st- Received September 17, 2009 roke, migraine, psychiatric symptoms, and progressive cognitive impairment. The clinical course Revised November 25, 2009 of CADASIL is highly variable, even within families. The involvement of the anterior temporal Accepted November 25, 2009 lobe and the external capsule on brain magnetic resonance imaging was found to have high sen- Correspondence sitivity and specificity in differentiating CADASIL from the much more common sporadic cere- Jay Chol Choi, MD, PhD bral small-vessel disease (SVD). The pathologic hallmark of the disease is the presence of gran- Department of Neurology ular osmiophilic material in the walls of affected vessels. CADASIL is a prototype single-gene and Institute of Medical Science disorder that has evolved as a unique model for studying the mechanisms underlying cerebral Jeju National University, SVD. At present, the incidence and prevalence of CADASIL seem to be underestimated due to School of Medicine, limitations in clinical, neuroradiological, and genetic diagnoses of this disorder.
    [Show full text]